Open AccessA Retrospective Assessment of the Initial Phase of Covid-19 and Its Implemented Treatment Strategies
Author(s) -
Pinkan Sadhukhan,
Innocent Sutnga,
Bharjil Bingari,
Ananta Choudhury
Publication year - 2021
Publication title -
journal of drug delivery and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2250-1177
DOI - 10.22270/jddt.v11i3-s.4868
Subject(s) - favipiravir , virology , pandemic , denial , coronavirus , covid-19 , medicine , intensive care medicine , disease , psychology , pathology , infectious disease (medical specialty) , psychoanalysis
Coronaviridae is a typical type of viral family comprised of an exceptionally huge RNA genome with a characteristic appearance and a noteworthy propensity to move from creatures to people. Since the start of the 21st century, three exceptionally contagious and pathogenic coronaviruses have traversed the species boundary and caused lethal pneumonia, exacting serious episodes, and causing human wellbeing crises to an unfathomable extent. The COVID-19 pandemic, presumably, is the most wrecking one, over the most recent 100 years after Spanish influenza. To the quick assessment of the various methodologies for a capability to evoke defensive resistance and well-being to shorten undesirable resistant potentiation, which assumes a significant function in this virus's pathogenesis. Considering the forthcoming public health crisis, researchers around the globe are consolidating their logical scientific possessions and offering initial information in an unprecedented way. In this review, we have tried to summarize some of the SAR-nCoV2 treatments that essentially focus on the potential drugs including Lopinavir/Ritonavir, Favipiravir, Remdesivir, Chloroquine phosphate, Hydroxychloroquine, Arbidol, and so on. Other potential vaccine developments with their difficulties associated and their current status are also being addressed.
Keywords: